ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

Subjects were followed for incident aortic stenosis or aortic valve disease through the National Patient Register and the National ... As HbA1c has become widely used in clinical practice to detect ...

with aortic stenosis (41 mild, 89 moderate, 34 severe; 7% bicuspid) who underwent echocardiography and contrast-enhanced CT as part of imaging studies. Calcific and non-calcific (fibrosis) valve ...

Patients were required to have severe aortic stenosis defined by either an aortic valve area of less than 0.8 cm2, an aortic valve gradient of at least 40 mm Hg, or a peak aortic jet velocity of ...

Aortic stenosis is treated medically until the valve area decreases to a critical point or the patient becomes symptomatic. Because valvular aortic stenosis is primarily a disease of aging ...

New Delhi: Global medical device maker Abbott has introduced the Navitor Vision in India, a state-of-the-art valve technology for treating symptomatic severe aortic stenosis in patients who face ...

Severe aortic stenosis (AS) is the most common degenerative heart valve disease and poses a ... BAV patients exhibited a lower aortic valve area compared with TAVI patients (0.58±0.16 cm² vs 0.70±0.24 ...

Coronary artery disease (CAD) is present in 40–75% of patients undergoing transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis. Currently, the indication for TAVI is ...

Myval THV matches SAPIEN and Evolut THVs in 30-day outcomes, supporting its role in severe aortic stenosis treatment.

were categorized into AS‐only (n=41 312) and AS–plus–ATTR‐CA (n=212) cohorts. AS indicates aortic stenosis; ATTR‐CA, transthyretin cardiac amyloidosis; AVR, aortic valve replacement; and CA, cardiac ...